权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Regulation of Insulin sensitivity by Glucocorticoid-Angiopoietin-like 4-Ceramide Axis

糖皮质激素-血管生成素样 4-神经酰胺轴调节胰岛素敏感性

基本信息

批准号：
10064621
负责人：
Jen-Chywan Wang
金额：
$ 36.27万
依托单位：
UNIVERSITY OF CALIFORNIA BERKELEY
依托单位国家：
美国
项目类别：
财政年份：
2017
资助国家：
美国
起止时间：
2017-12-07 至 2022-11-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10064621
关键词：
ANGPTL4 gene Adipocytes Adipose tissue Attenuated Biology Cardiovascular Diseases Ceramides Chronic Data Disease Dyslipidemias Exposure to Fasting Fatty Acids Fatty Liver Fibrinogen Functional disorder Genes Genetic Transcription Glucocorticoids Glucose Glucose Clamp Goals Hepatic Hypertriglyceridemia Impairment Insulin Insulin Resistance Knockout Mice Knowledge Lipid Mobilization Lipolysis Liver Mediating Metabolic Metabolic Diseases Modeling Molecular Molecular Target Mus Non-Insulin-Dependent Diabetes Mellitus Nonesterified Fatty Acids Outcome Study PPAR alpha Pathway interactions Peripheral Play Process Production Protein Phosphatase 2A Regulatory Subunit PR53 Proteins Risk Role Signal Transduction Stress Synthetic Genes Testing Therapeutic Intervention Time Tissues base dihydroceramide desaturase expectation extracellular fatty acid transport glucose production improved insight insulin regulation insulin sensitivity lipoprotein lipase novel overexpression response thermozymocidin transcriptome sequencing uptake

项目摘要

Abstract Glucocorticoids (GC) play a key role in metabolic adaptation during stress. However, chronic exposure to GC, is harmful and results in disorders such as insulin resistance. We previously identified angiopoietin-like 4 (Angptl4) as a GC-regulated gene encoding a secreted protein that promotes adipocyte lipolysis and inhibits extracellular lipoprotein lipase (LPL). We showed that Angptl4 is required for GC-promoted lipolysis in white adipose tissue (WAT) and in Angptl4 null mice (Angptl4-/-), excess GC-induced fatty liver and hypertriglyceridemia are diminished. Our recent preliminary studies further demonstrated that GC-induced insulin resistance was compromised in Angptl4-/- mice. Intriguingly, GC treatment increased hepatic ceramide levels, but such GC effect was attenuated in the absence of Angptl4. Indeed, myriocin, which inhibits ceramide synthesis, decreased GC-induced insulin resistance in wild type (WT) but not Angptl4-/- mice. We additionally found that GC exposure elevated the activity of PP2A and PKCζ (two downstream effectors of ceramides) as well as the expression of a list of ceramide synthetic genes in liver. In Angptl4-/- mice, the activity of PP2A and PKCζ was mitigated and the expression of ceramide synthase 3-6 (Cers3-6) was specifically impaired. Based on these preliminary data, we hypothesize that GC augment the expression of Angptl4, which promotes WAT lipolysis mobilizing fatty acids (FA) to liver to serve as substrates and signals required for GC to increase Cers3-6 expression. This elevates the production of specific ceramide species to activate PP2A and PKCζ to suppress insulin action. In this proposal, we will examine this model. In Aim 1, our preliminary study found that the fibrinogen-like domain (FLD) of Angptl4 promotes adipocyte lipolysis without inhibiting LPL. We will test whether FLD restores GC-induced insulin resistance in Angptl4-/- mice. We will also examine the role of FA mobilization to the liver in GC-induced insulin resistance using mice with reduced expression of two major hepatic FA transporters, Fatp5 and Cd36. Moreover, hyperinsulinemic- euglycemic clamps will be used to determine the role of Angptl4 in GC-augmented hepatic glucose production, a hallmark of hepatic insulin resistance. In Aim 2, we will determine which ceramide synthase(s), Cers3-6, are involved in GC-induced insulin resistance. PPARα can be activated by FA and has been shown to increase ceramide synthesis in certain tissues. Thus, its role in GC-induced hepatic Cers3-6 expression and ceramide production will be examined. In Aim 3, we will analyze the role of PP2A and PKCζ in GC- induced insulin resistance and will identify ceramide synthase(s) that activate PP2A and PKCζ to cause insulin resistance. Overall, this study will be the first to establish the FLD of Angptl4 as a lipid mobilization factor participating in GC-induced insulin resistance and for the first time, specific ceramide synthases that activate PKCζ and PP2A will be identified. These findings will advance our understanding of the mechanism of insulin resistance and will provide novel molecular targets for improving insulin sensitivity. ! !

摘要